Blog

Introduction to my Metabolic Protocol

I’m on a mission: either cure cancer or advance scientific understanding in the process. Join my journey on this blog, and please consider donating to support my efforts. To simplify a complex mechanism: cancer struggles to utilize fat for fuel. By entering a therapeutic state of ketosis, we can deprive it of glucose, its primary energy source, leaving just glutamine. …

Protocol 6 – Pretty much the whole thing

Hello everyone, I hope you’ll share in my joy, but I apologize for not keeping my blog current. I’ve been deeply engrossed in learning with my vibrant new community. In a previous post, I expressed my excitement about finally connecting with others following the same protocol. However, my relief and support since then have far exceeded my expectations. I’ve learned …

Protocol 5 – DON Doses 4-6

They say no news is good news, and in this case, it’s true—though I wouldn’t generally trust that old phrase. For doses 4 and 5, I did exactly the same as for doses 2 and 3, experiencing no side effects. But then came dose 6, my last of Protocol 5. I foolishly decided to eat a piece of toast in …

Protocol 5 – DON doses 2 and 3

For the second dose of this protocol (Friday, June 28th), I stuck with the enteric-coated capsules. This is becoming my new standard unless I switch to subcutaneous injections, which seems unlikely, at least not before my following scan. If my breast tumour disappeared back in the fall of 2023 when I was taking DON orally (and losing half to stomach …

Protocol 5 – DON Dose 1

Hello everyone, As I mentioned in my previous post, I decided to try a new method to improve DON absorption. Ideally, an IV or subcutaneous administration would be best, but that’s a bit above my pay grade right now. I might consider subcutaneous in the future if I can figure out the reconstitution values from previous studies. I haven’t delved …

Protocol 5 – Exploring a New Method for Enhancing DON Absorption

Hello everyone, I recently revisited the effectiveness of my current method for taking 6-Diazo-5-oxo-L-norleucine (DON) and discovered some potentially significant improvements. After discussing it with a researcher from Seyfried’s lab, I learned that DON, like many small molecules and amino acid derivatives, is primarily absorbed in the small intestine. This insight led me to reconsider how I administer DON to …

The Thrill of Finding a Community:

On a high note—and for a change, not a rant—I’ve found my tribe! We’re a community of fellow experimenters, a bit rogue perhaps, navigating uncharted waters because traditional methods just haven’t delivered for us. We’re diligently piecing together research from Thomas Seyfried’s Press/Pulse Mitochondrial Metabolic Theory and various mouse studies and creating treatments that veer off the beaten path. And …